6 results
diabetes diagnosis dm2 adrenal algorithm congenital deficiency dosing glftap glp1 hydroxylase hyperplasia hyperthyroidism inhibitors interpretation macroadenoma masseffects mnemonic oral pathophysiology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology ... GLP-I receptor agonist ... failure Common Side Effects ... #Inhibitors #Pharmacology ... DM2 #diabetes #endocrinology
Congenital Adrenal Hyperplasia - 21-Hydroxylase Deficiency - Signs and Symptoms • Brain: Androgenization effects, Glucocorticoid effects,
Hydroxylase Deficiency - Signs ... Glucocorticoid effects ... • Hypothalamic–Pituitary ... Hydroxylase #Deficiency #Signs ... Symptoms #diagnosis #endocrinology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
Common side effects ... the product, it can ... very similar to DPP4s ... #Pharmacology #Dosing ... Diabetes #DM2 #Endocrinology
Approach to Thyroid Function Tests in the Evaluation of Hyperthyroidism • Low TSH, Low normal T4
Can repeat labs ... , and dopamine agonists ... Hyperthyroidism → Signs ... Hyperthyroidism → MRI Pituitary ... algorithm #diagnosis #endocrinology
Pituitary Mass Effects - Pathogenesis and Clinical Findings • Pituitary turnors are almost always a benign
Pituitary Mass Effects ... Pituitary adenomas ... secreting tumors can ... Signs / Symptoms ... #SideEffects #endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
First Oral GLP-1 Agonist ... only) oral GLP1 agonist ... empagliflozin and DPP4 ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
No results found for "Defects+signs collateral pharmacology endocrinology pituitary dpp4 agonists cah"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Defects+signs #collateral #pharmacology #endocrinology #pituitary #dpp4 #agonists #cah